Global Genomics Market 2025–2034

The Global Genomics Market Size was worth USD 44.22 billion in 2025, and it is expected to be worth USD 189.02 billion by the end of 2034, with a compound annual growth rate (CAGR) of about 17.33% from 2025 to 2034.

The COVID-19 pandemic had a big effect on the market because it caused a lot of growth and demand. Recent technological advances in the market have helped it grow. There will be positive growth in the next few years because a lot of new businesses have opened. The government is giving more money to genome projects, and more of them will help the market grow in the next few years. Research in this area can lead to the most effective treatments. Different governments in different parts of the world are working on programs to get more research done in the area.

Market Changes

Drivers

Many genomics projects were started by governments in different parts of the world, and the money from these governments will help the market grow in the next few years. Investments will be very important for the growth of the market. Because the government is putting more money into research, new technologies will be created. For instance, in 2019, $224 million was put into a project to sequence genomes. A partnership started this project to help improve the diagnosis and treatment of a number of illnesses. It would help people who have diabetes, heart disease, cancer, dementia, or arthritis.

Limits

The Genomics market had a lot of room to grow, but the lack of trained technicians would slow its growth in the next few years. If there is a shortage, the market will not grow as quickly. In most developing countries, the lack of trained technicians will hurt the market. The high cost of the tools will also have an effect on market growth.When it comes to making new products, rules and regulations are very strict. There is a greater need for early detection of diseases, which is a good thing, but the rules will slow the growth of the market.

Chances

There are a lot of chances for the genomics market to grow because more and more people want personalized medicine. In recent years, more and more pharmaceutical companies have put money into research for personalized medicines. One of the most important things that will help the market grow is figuring out exactly what people need. Patients' prescriptions and treatments are determined by personalization.

This kind of research helps to get better results. Personalized treatments have made it easier for patients to follow their doctor's orders and made drug administration safer. This is a cost-saving offer, and it also helps make the best use of therapies. This method and the experiments can be used to look at a person's genes and figure out what to do next. In the next few years, precision medicine is likely to grow a lot. All of these things will open up good chances.

Problems

The large amount of data that comes from the research activity needs to be looked at. It becomes difficult to analyze this huge amount. To interpret is a job. Hiring and training these people is also expensive because there aren't many trained people available around the world. All of these problems will make it harder for the Genomics market to grow. As things have gotten more complicated, there is also a growing need for in-depth knowledge. Because research and improvements in techniques are always happening, the skills that people need are changing. This means that there is a growing need for qualifications and the right training.

Key Points from the Report

The functional genomics segment has been the most popular in the past and will keep growing well in the next few years, based on Application. This part made the most money. The pathway analysis segment, on the other hand, will have the highest compound annual growth rate in the next few years. Researchers use pathway analysis to try to learn the basics of molecular and cellular biology.

Based on what they deliver, the products segment is likely to have a bigger share of the Genomics market in terms of revenue. Because manufacturers are always making new products, this segment is likely to bring in the most money compared to the services segment. Also, big companies are buying small ones to make their products better.

In the next few years, the biotechnology and pharmaceutical company segment will have a bigger share of the market. These businesses are using genomics technologies more often. The market has also grown because there is a growing need for research. Genomics is very important for finding and making new drugs.

Snapshots of Regions

In the next few years, the North American region is likely to have a good market share. There have been more strategic partnerships in the past few years, which should lead to growth in the North American market. Also, the FDA has given more regulatory approvals in the last few years. There is good growth in the market because the rules in this area are also changing. Policies that make it easier for people to get paid back are also likely to help the market grow. The Asia Pacific region is also expected to grow in the same way as the North American region, in addition to the North American region growing.

As the need for genetic sequencing grows in places like China, the Asia Pacific region is expected to grow at a very high compound annual growth rate in the next few years. There has been a lot of demand for making drugs for rare diseases, so the genomics market is expected to grow well in the next few years. There will be a lot of growth in places like the Middle East, Africa, and Latin America. Government programs in these areas will help the market grow.

Scope of the Report

Details about the Report's Features

Market Size in 2025: $44.22 Billion

Estimated Market Size in 2034: $189.02 Billion

CAGR Growth Rate: 17.33% CAGR

Year of Base - 2024

Time Frame for the Forecast: 2025–2034

Main Segment: By Application, Deliverables, End User, and Region

Report Coverage: Company Profile, Revenue Estimation and Forecast, Competitive Landscape, Growth Factors, and Recent Trends

North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America are all included in the regional scope. Show more